These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30655333)

  • 21. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program.
    Flannery B; Samad S; de Moraes JC; Tate JE; Danovaro-Holliday MC; de Oliveira LH; Rainey JJ
    Vaccine; 2013 Mar; 31(11):1523-8. PubMed ID: 23313652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador.
    Suarez-Castaneda E; Burnett E; Elas M; Baltrons R; Pezzoli L; Flannery B; Kleinbaum D; de Oliveira LH; Danovaro-Holliday MC
    Vaccine; 2015 Nov; 33(48):6865-70. PubMed ID: 26263200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Challenge of Achieving Immunity Through Multiple-Dose Vaccines in Madagascar.
    Jones FK; Mensah K; Heraud JM; Randriatsarafara FM; Metcalf CJE; Wesolowski A
    Am J Epidemiol; 2021 Oct; 190(10):2085-2093. PubMed ID: 34023892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey.
    Hoppenbrouwers K; Kanra G; Roelants M; Ceyhan M; Vandermeulen C; Yurdakök K; Silier T; Dupuy M; Pehlivan T; Ozmert E; Desmyter J
    Vaccine; 1999 Feb; 17(7-8):875-86. PubMed ID: 10067694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel.
    Stein-Zamir C; Israeli A
    Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.
    Domenech de Cellès M; Rohani P; King AA
    JAMA Pediatr; 2019 Jun; 173(6):588-594. PubMed ID: 31009031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care.
    Masseria C; Buikema AR; Liu F; Krishnarajah G
    Hum Vaccin Immunother; 2015; 11(5):1175-83. PubMed ID: 25714800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines.
    Wondimu A; Cao Q; Wilschut JC; Postma MJ
    BMC Public Health; 2019 Dec; 19(1):1656. PubMed ID: 31823756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
    Pichichero ME; Latiolais T; Bernstein DI; Hosbach P; Christian E; Vidor E; Meschievitz C; Daum RS
    Pediatr Infect Dis J; 1997 Sep; 16(9):863-70. PubMed ID: 9306481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
    Klein NP; Abu-Elyazeed R; Cheuvart B; Janssens W; Mesaros N
    Hum Vaccin Immunother; 2019; 15(4):809-821. PubMed ID: 30444673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.
    Church JA; Chasekwa B; Rukobo S; Govha M; Lee B; Carmolli MP; Ntozini R; Mutasa K; McNeal MM; Majo FD; Tavengwa NV; Kirkpatrick BD; Moulton LH; Humphrey JH; Prendergast AJ
    Vaccine; 2020 Mar; 38(13):2870-2878. PubMed ID: 32088018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):521-4. PubMed ID: 20448529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study.
    Ai CE; Steele M; Lopman B
    PLoS One; 2020; 15(2):e0228942. PubMed ID: 32059029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rotavirus vaccination in the US: a systematic review of vaccination coverage and completion.
    Ghaswalla PK; D'Angelo J; Abu-Elyazeed R
    Hum Vaccin Immunother; 2021 Mar; 17(3):872-879. PubMed ID: 32845792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
    López P; Arguedas Mohs A; Abdelnour Vásquez A; Consuelo-Miranda M; Feroldi E; Noriega F; Jordanov E; B Chir S; Zambrano B
    Pediatr Infect Dis J; 2017 Nov; 36(11):e272-e282. PubMed ID: 28719500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study.
    Gillard P; Tamura T; Kuroki H; Morikawa Y; Moerman L; Parra J; Kitamura Y; Mihara K; Okamasa A
    Hum Vaccin Immunother; 2019; 15(4):800-808. PubMed ID: 30785851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana.
    Harris VC; Armah G; Fuentes S; Korpela KE; Parashar U; Victor JC; Tate J; de Weerth C; Giaquinto C; Wiersinga WJ; Lewis KD; de Vos WM
    J Infect Dis; 2017 Jan; 215(1):34-41. PubMed ID: 27803175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
    Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.